- Home
- VKTX vs GOLF Comparison
VKTX vs GOLF Comparison
Compare VKTX & GOLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- GOLF
- Stock Information
- Founded
- VKTX 2012
- GOLF 1910
- Country
- VKTX United States
- GOLF United States
- Employees
- VKTX N/A
- GOLF N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- GOLF Recreational Games/Products/Toys
- Sector
- VKTX Health Care
- GOLF Consumer Discretionary
- Exchange
- VKTX Nasdaq
- GOLF Nasdaq
- Market Cap
- VKTX 4.6B
- GOLF 4.5B
- IPO Year
- VKTX 2015
- GOLF 2016
- Fundamental
- Price
- VKTX $42.25
- GOLF $69.83
- Analyst Decision
- VKTX Strong Buy
- GOLF Buy
- Analyst Count
- VKTX 12
- GOLF 5
- Target Price
- VKTX $106.75
- GOLF $71.40
- AVG Volume (30 Days)
- VKTX 3.7M
- GOLF 260.1K
- Earning Date
- VKTX 02-05-2025
- GOLF 11-07-2024
- Dividend Yield
- VKTX N/A
- GOLF 1.23%
- EPS Growth
- VKTX N/A
- GOLF N/A
- EPS
- VKTX N/A
- GOLF 2.93
- Revenue
- VKTX N/A
- GOLF $2,424,883,000.00
- Revenue This Year
- VKTX N/A
- GOLF $5.63
- Revenue Next Year
- VKTX N/A
- GOLF $3.74
- P/E Ratio
- VKTX N/A
- GOLF $23.85
- Revenue Growth
- VKTX N/A
- GOLF 0.35
- 52 Week Low
- VKTX $17.23
- GOLF $58.54
- 52 Week High
- VKTX $99.41
- GOLF $76.59
- Technical
- Relative Strength Index (RSI)
- VKTX 33.93
- GOLF 43.03
- Support Level
- VKTX $37.80
- GOLF $68.99
- Resistance Level
- VKTX $48.55
- GOLF $76.59
- Average True Range (ATR)
- VKTX 2.54
- GOLF 1.88
- MACD
- VKTX -0.45
- GOLF -0.90
- Stochastic Oscillator
- VKTX 30.11
- GOLF 11.04
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About GOLF Acushnet Holdings Corp.
Acushnet Holdings Corp is engaged in the design, development, manufacture, and distribution of golf products. Its product category includes golf balls, golf shoes, golf clubs, wedges, putters, golf gloves, golf gear and golf wear, of which key revenue is derived from the sales of golf balls and golf gloves. The operating segments of the company are Titleist golf balls, Titleist golf clubs, Titleist golf gear and FootJoy golf wear. Geographically, the company operates in the United States, EMEA, Japan, Korea and other countries, of which a majority of the revenue is generated from the operations in the United States.